Activity in this selectionredmile-group-f2c1aad9
- Rounds participated in
- 1
- Confirmed lead rounds
- —
1 roles undisclosed- New companies
- 1
First participation on record · 0 follow-on- Funding in participating rounds
- $66M
1 disclosed · full round size, not this investor’s share
Rounds
1 in this selectionAbcuroDevelops immunotherapies that selectively deplete cytotoxic T cells to treat autoimmune diseases
Role not disclosed